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ABSTRACT
Background: To help the growing number of cancer survivors deal with the challenges of cancer sur-
vivorship, survivorship care plans (SCPs) were recommended by the Institute of Medicine (IOM) in
2006. The SCP is a formal document that contains both a tailored treatment summary and a follow-up
care plan. Since the IOM recommendation 10 years ago, the implementation in daily clinical practice is
minimal. Several studies have investigated the effects of SCPs on patient-reported outcomes and
oncology and primary care providers (PCPs), but the quantity and quality of these studies are limited.
Results: The first four randomized trials comparing SCP delivery with usual care failed to show a posi-
tive effect on satisfaction with information provision, satisfaction with care, distress or quality of life.
SCPs did improve the amount of information provided and communication of PCPs with medical spe-
cialists and patients. A recent small trial that changed the focus from SCP as primarily an information
delivery intervention to a behavioral intervention did observe positive effects on self-reported health,
lower social role limitations and a trend towards greater self-efficacy. Gaps in knowledge about SCPs
include uncertainty about content and length of the SCP; whether it should be delivered online or on
paper; the timing and frequency of delivery; which health care provide should deliver SCP care. Finally,
cost-effectiveness of SCP interventions has received limited attention.
Conclusion: Currently, there is not enough evidence to warrant large-scale implementation of SCPs, or
to abandon SCPs altogether. Emphasis on the SCP process and survivor engagement, supporting self-
management may be an important way forward in SCP delivery. Whether this is beneficial and cost-
effective on the long term and among different groups of cancer survivors needs further investigation.
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As a result of improved early detection, improved treatments
and the ageing of the population, the number of cancer sur-
vivors is rapidly increasing in developed countries. As many
of these cancer survivors continue to live with long-term or
late physical and psychosocial effects of their cancer and
treatment, it is important to address their specific health care
needs [1,2].
Providing tailored information that corresponds to patients’
needs is a key factor in the support for cancer survivors during
follow-up care [3–5], but unmet information needs are fre-
quently found among cancer survivors [6]. Unmet information
needs have been associated with more psychological com-
plaints, and higher levels of anxiety and depression [5].
To help the growing number of cancer survivors deal with
the challenges of cancer survivorship, survivorship care plans
(SCPs) were recommended by the Institute of Medicine (IOM)
in 2006 [2]. The SCP is a formal document that contains both
a tailored treatment summary (including information on diag-
nostic tests, type of cancer, stage, grade, treatment, and con-
tact details of the hospital and specialists), and a follow-up
care plan (including information on possible short-term and
long-term effects, effects on social and sexual life, signs of
recurrence and secondary tumors, rehabilitation, psychosocial
support, and supportive care services). SCPs are expected to
meet cancer survivors’ information needs, to facilitate follow-
up care for cancer survivors, and to enable better communi-
cation between the health care providers involved in the
follow-up care. Based on their face validity, the IOM advised
that SCPs should be implemented for all cancer survivors [2].
Since the IOM recommendation 10 years ago, several stud-
ies have investigated the effects of SCPs on patient-reported
outcomes. In 2015, Mayer and colleagues conducted an inte-
grative review (to summarize evidence from studies with
diverse methodologies) that included studies focusing on SCP
content, implementation and impact on outcomes [7]. They
conclude that although SCP use is endorsed, implementation
is not yet widespread and evidence of improved outcomes is
limited. Mayer et al. give a comprehensive overview of the
current evidence and finally summarize areas for future
research that will answer open questions like ‘When, how,
which, what, whom’ to use SCP care. In this current perspec-
tive we aim to further the field of SCP care by bringing focus
in these areas for future research. Based our own experience
of barriers and facilitators in implementing SCP care in the
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pragmatic cluster randomized ROGY Care trial [8], Mayer’s
review outcomes, and new evidence from the recently pub-
lished POSTCARE trial [9] we suggest which specific aspects of
SCP content and dissemination deserve further investigation.
We discuss highest level evidence studies when possible,
meaning that we only discuss results of randomized con-
trolled trials (RCTs) if available, and only include outcomes of
level II or III evidence studies if RCTs are not available.
Impact of survivorship care plans on
patient-reported outcomes
Three early randomized studies [10–12] did not find any dif-
ferences in satisfaction with care [10–12], distress [12] and
quality of life [12] between patients who did or did not
receive an SCP. Although these studies provided important
first insights into the impact of SCPs, there were limitations
in the study designs, including the timing of the intervention
and outcomes assessment [13].
The recently published outcomes of our pragmatic cluster
randomized ROGY Care trial among 221 endometrial cancer
patients revealed that patients in the SCP care arm reported
receiving more information about their treatment, other serv-
ices and different places of care than patients in the usual
care arm. However, there were no differences regarding satis-
faction with the received information or care. In addition,
patients in the SCP care arm experienced more symptoms,
were more concerned about their illness, more affected emo-
tionally, and reported more cancer-related contact with their
PCP than patients in the usual care arm [8]. A secondary
analyses evaluated the impact of an automatically generated
paper SCP in patients who searched for disease-related infor-
mation on the internet and those who did not [14]. Paper
SCPs appeared to improve the amount of received informa-
tion about the disease and medical tests, the helpfulness of
the information, and the understanding of the illness for
patients who did not search for disease-related information
on the internet themselves (n¼ 141; 64%). In contrast, paper
SCPs did not seem beneficial for patients who did search for
disease-related information on the internet.
In contrast to the first four SCP trials that failed to have
shown impact on patient-reported outcomes, the 2016 pub-
lished POSTCARE trial among 79 breast cancer patients
appeared to have a positive impact on self-reported health,
lower social role limitations and a trend towards greater self-
efficacy [9]. The POSTCARE trial placed priority on the SCP
process and survivor engagement rather than the SCP docu-
ment. The intervention included a single coaching encounter
using motivational interviewing to engage patients in the
development of their own SCP. Patients were assisted by a
coach to set individual health goals and strategies related to
cancer follow-up, surveillance, symptom management and
health behavior.
Experiences of survivorship care plan use among
oncology providers
Previous studies investigating the views of oncology pro-
viders (i.e. medical specialists and oncology nurses) who
deliver the SCPs, have found that oncology providers’ views
regarding SCPs are generally positive [15,16], but implemen-
tation of SCPs has been limited [17,18]. Oncology providers
experience substantial barriers to SCP use, including finding
the time, reimbursement, personnel and resources necessary
to create SCPs [18–20]. It has therefore been proposed that
automatic generation of SCPs may ease some of the burden
on oncology providers [15,21].
Longitudinal evaluation of expectations and experiences
of oncology providers in the ROGY Care trial revealed that
oncology providers were generally satisfied with the auto-
matically generated SCP [22]. They believed the SCP affected
patients positively, and were also motivated to keep using
the SCP. Automatic generation of the SCP appeared to
improve resources necessary to create SCPs. Nevertheless,
most oncology providers (64%) still encountered barriers in
providing SCP care in daily clinical practice. The most fre-
quently reported practical barrier was finding the time to
discuss the SCP.
Experiences of survivorship care plan use among
primary care providers
Transferring routine follow-up care from the medical special-
ist to the PCP has also been suggested as an important strat-
egy to meet the growing demand for oncology resources
[23]. This would require effective sharing of information
between medical specialists, PCPs and patients. In the first
SCP trial by Grunfeld et al. among 408 breast cancer survi-
vors the SCP did not contribute beyond the control condition
in transferring routine follow-up care to primary care [12],
although more patients in the intervention arm identified the
PCP as primarily responsible for their follow-up care. In the
ROGY Care trial SCP care improved the frequency and quality
of the communication between the medical specialist and
the PCP, and supported the contact of PCPs with patients
[24]. This suggests that SCPs may be a useful tool to enable
this transition, although in the ROGY Care trial only one third
of the PCPs in the SCP care arm indicated having received an
SCP. In the POSTCARE trial a greater percentage of the partic-
ipants in the intervention arm reported an office-confirmed
PCP visit and discussion of the SCP with their PCP than the
control arm [9]. However, potentially related to the small
sample size of this study, the findings did not reach statistical
significance.
Should survivorship care plans be implemented for
all cancer survivors?
In the US, in order to earn accreditation, the Commission on
Cancer (CoC) requires Cancer Programs to disseminate a
comprehensive care summary and follow-up plan to patients
with cancer who are completing cancer treatment [25].
However, at present for those in the field who have a choice,
we would not recommend to start implementing SCPs for all
cancer survivors, based on several considerations. First of all,
there is no substantial evidence of a benefit of SCPs. Except
for the first positive impact on patient outcomes in the
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recently published small POSTCARE trial [9], no differences in
satisfaction with information provision [8], satisfaction with
care [10–12], distress [12], and quality of life [12] have been
found between patients who did or did not receive an SCP.
Second, at this point, no definitive statements can be made
about the potential negative consequences of SCPs. In the
ROGY Care trial, receiving an SCP increased the degree to
which the illness was perceived as threatening and the
amount of cancer-related contact with the PCP. It is unclear
whether these consequences are beneficial, facilitating
patients’ self-monitoring, or harmful, leading to unnecessary
distress and overconsumption of health care. Third, it is
unclear whether the effects of SCPs are different for different
patients groups. As we observed that outcomes of SCPs are
different for patients who do or do not search the internet
for disease-related information [14], it is likely that there are
more patient characteristics that influence the impact of
SCPs. Fourth, cost-effectiveness of the SCP has only been
established in one trial, showing that it is costly to introduce
on a large scale and not cost-effective [26]. Finally, even if
larger scale implementation of SCPs would be warranted,
practical barriers, such as time constraints, need to be
addressed before SCPs can be more widely adopted.
Although SCPs could be automatically generated in the
ROGY Care trial, oncology providers still had difficulties find-
ing the time to discuss the SCP with all of their patients.
However, at present, there is also not enough empirical
evidence to warrant abandoning SCPs altogether. Essential
gaps in the knowledge about SCPs need to be thoroughly
examined in future research before conclusive statements
can be made. These studies need to evaluate new ways to
further decrease barriers and optimize the use of SCPs in
clinical practice. Finally, it is possible that so far, no benefits
of SCPs have been found, because the influences of the con-
tent, length, format and delivery of SCPs on the outcomes of
SCPs have received limited attention [7,9].
Survivorship care plan content and length
Previous research indicates that cancer survivors and PCPs
have different preferences regarding the content and length
of SCPs [7]. In general, cancer survivors prefer more detail
rather than less [27], and want more information on health
promotion, psychosocial support and other resources [7].
PCPs preferred a more concise SCP that is focused on their
specific needs (i.e. focusing on diagnosis, treatment, and pos-
sible consequences) [24]. Consequently, it would be problem-
atic to create one SCP that is tailored to both the needs of
patients and PCPs [27]. For that reason, it may be better to
make different SCPs for patients and PCPs that are tailored
to their specific needs.
There is a lack of consensus regarding the optimal content
and length of SCPs for patients [27]. If an SCP consists of all
components recommended by the IOM, thus containing both
a treatment summary and a follow-up care plan it could be
up to 20 pages long, depending on a patient’s specific situ-
ation. However, providing this amount of information, par-
ticularly on possible side effects and recurrence of the
cancer, may also cause distress in some patients [8]. A study
that assessed the effectiveness of a one-page SCP among
Hodgkin lymphoma survivors, found that 91% of the patients
were positive about the SCP, and that the SCP did not
increase patients’ tension and anxiety [28]. It is possible that
providing a shorter SCP that includes only the most import-
ant information may have similar results regarding patients’
perceived information provision as a longer SCP, while hav-
ing less emotional impact on patients. In addition, a shorter
SCP may minimize the required resources and may increase
the use of the SCP. As the difficulty of implementing SCPs in
practice has become more of a concern for clinicians, given
that the CoC now requires this for accreditation [25], ASCO
has developed a clinical expert statement that defines the
minimum elements needed to complete an SCP. This should
serve the needs of patients and their families and PCPs car-
ing for those survivors after cancer treatment [29].
Moreover, it may be useful for health care providers to tai-
lor (part of) the content and length of the SCP to patients’
individual needs, by asking their patients whether they
would like to receive certain information or not. The internet
may provide a useful setting for tailoring the content and
length of the information provision.
Survivorship care plan format: paper versus online
Although SCPs were originally designed to be printed on
paper and delivered by the oncology provider [2], it is also
possible to provide patients with access to an online SCP.
Online dissemination of SCPs may have several advantages
over paper SCPs, such as possibly taking less time for health
care providers and making it easier to exchange the SCP
between health care providers. In addition, it may be easier
to adapt an online SCP to patients’ specific information
needs, by providing patients with the option to click on
more information if they want to, but not to click on infor-
mation if they do not want to receive the information. To be
of added value, the online SCP should entail more than
merely providing the content of the paper SCP online. A sug-
gestion would be to provide patients with access to a tail-
ored online portal, where information from different sources
is brought together to help these patients find reliable infor-
mation and resources online. For instance, in addition to
access to their own medical file and contact details of the
hospital and specialists, the portal could provide access to
different online sources of information that are tailored to
their specific situation, and direct access to different online
services that provide supportive care and psychosocial
support.
However, not all patients may benefit from online dissem-
ination of SCPs. For instance, patients who are older, lower
educated or do not have a partner or a job are less likely to
use the internet [30,31]. Paper SCPs appear to be beneficial
for patients who do not search for disease-related informa-
tion on the internet [14]. Providing an SCP that can only be
accessed on the internet may therefore alienate patient
groups that actually need the support the most. A recent
review [7] showed that both paper and online SCPs are
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considered useful by cancer survivors and that some patients
prefer to receive both. Based on the current evidence, we
would propose that, ideally, health care providers tailor the
SCP format to patients’ preferences, by asking patients how
they would like to receive the SCP: printed on paper, an
account that gives access to an online SCP, or both. Future
research needs to investigate whether this approach is effect-
ive and feasible in routine clinical practice.
Survivorship care plan timing and frequency of
delivery
In previous studies, the moment of the delivery of the SCP
ranged from newly diagnosed patients to patients who were
up to six years post-treatment [8–12]. Although the IOM rec-
ommended delivering the SCP at the end of treatment [2], it
may be preferable to provide the SCP directly after initial
diagnosis, allowing patients to discuss the planned treatment
with their oncology providers and family [27]. The POSTCARE
trial targeted cancer survivors within one year after the com-
pletion of active treatment [9], based on input from survivors
which indicated that the acute survivorship transition was
the most stressful. The authors suggest that the optimized
timing of the support in their trial may have contributed to
the positive impact of their intervention.
The impact of the timing of the delivery of an SCP should
be further investigated, by comparing whether providing the
SCP directly after initial diagnosis leads to different outcomes
than providing the SCP at the end of treatment.
Moreover, as patients’ need for information may be differ-
ent at different time points in the follow-up trajectory, a sin-
gle SCP may not be sufficient. It has therefore been
suggested to provide updates of the SCP in follow-up consul-
tations, rather than a single, static SCP [32]. However, it is
unclear whether constraints in clinical practice would limit
oncology providers’ ability to provide these updates. In the
ROGY Care trial, a third of the patients in the SCP care arm
actually received more than one SCP, suggesting that auto-
matically generating SCP updates from a registration system
may ease some of the potential barriers in clinical practice
[8]. Nevertheless, it is important to consider that, although
updates of the SCP could be provided in the ROGY Care trial,
patients still received nearly all of the information in the first
SCP. Consequently, patients already received information
about possible long-term and late effects directly after initial
diagnosis. It may be better to provide the information in the
SCP in different parts at different time points, so that
patients only receive information that is directly relevant for
them at that specific time.
Who should deliver the survivorship care plan?
There is no clear consensus regarding who should develop
and provide the SCP [9,27]. In the ROGY Care trial the major-
ity of the oncology providers indicated that the oncology
nurse should provide the SCP [22]. As we did not ask the
oncology providers about their motivation, their motives for
this preference remain unclear. It is possible that oncology
providers consider providing the information and follow-up
plan in SCPs primarily as a task for oncology nurses.
However, it is also possible that this finding partly reflects
the perceived time barriers. The recent POSTCARE trial [9]
took a radical different approach by emphasizing the care
plan delivery as a behavioral intervention, rather than a focus
on delivery of information. The survivorship coaching inter-
vention was delivered by master-level mental health care
professionals who completed motivational interviewing train-
ing. As the POSTCARE trial was the first to show positive
patient outcomes, the framing of the SCP within a chronic ill-
ness management model that stimulates self-management
deserves further research. Cost-effectiveness of the mental
health care professional as survivorship transition coach
should be further investigated.
Concluding remarks
Using SCPs to help cancer survivors deal with the long-term
or late effects of their cancer was proposed by the IOM in
2006. Ten years later, there is not enough evidence to war-
rant large-scale implementation of SCPs, or to abandon SCPs
altogether. Although the first four trials failed to show a posi-
tive effect on patient-reported outcomes, SCPs improved the
amount of information provided and communication of PCPs
with medical specialists and patients. Interestingly, a recent
study that changed the focus from SCP as primarily an infor-
mation delivery intervention to a behavioral intervention
revealed the first positive effects on patient outcomes. The
emphasis on the SCP process and survivor engagement, sup-
porting self-management may be an important way forward
in SCP delivery. Whether this is beneficial and cost-effective
on the long term and among different groups of cancer sur-
vivors needs further investigation. It is important to bear in
mind that SCPs are not a purpose in itself, but merely a pos-
sible tool to improve the quality of information provision and
follow-up care for cancer survivors.
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